Literature DB >> 2541610

Renal concentration defect induced by cisplatin. The role of thick ascending limb and papillary collecting duct.

A C Seguro1, M H Shimizu, L H Kudo, A dos Santos Rocha.   

Abstract

The effects of cisplatin (5 mg/kg BW given intraperitoneally) on renal concentration mechanism were evaluated initially by clearance studies in rats 5-7 days after cisplatin administration and compared to normal rats. During hypotonic saline infusion, cisplatin rats showed a lower inulin clearance (0.56 +/- 0.07 vs. 1.12 +/- 0.09 ml/min/100 g BW, p less than 0.01), a higher fractional distal delivery (CNa + CH2O/Cin) (36.3 +/- 4.4 vs. 22.8 +/- 4.5%, p less than 0.05), and lower CH2O/CNa + CH2O (33.6 +/- 5.8 vs. 56.5 +/- 5.0%, p less than 0.01). During hypertonic saline infusion the TcH2O/Cosm was lower in cisplatin (18.3 +/- 1.1%) than in normal rats (33.4 +/- 3.5%, p less than 0.01). These results suggest a defect in NaCl transport in the thick ascending limb of Henle and proximal tubule. In order to characterize these tubular defects, we measured Na-K-ATPase activity (microM Pi/mg protein/h). In the renal cortex of cisplatin rats the ATPase activity was lower (18.1 +/- 3.2) than in normal rats (33.4 +/- 6.4, p less than 0.05), also in the inner strip of the outer medulla of cisplatin rats Na-K-ATPase was reduced (26.0 +/- 5.7) when compared with normal rats (67.3 +/- 9.2, p less than 0.01), presumably representing a decrease in enzyme activity in the thick ascending limb.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541610     DOI: 10.1159/000167938

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  6 in total

1.  Dynamic contrast-enhanced MRI promotes early detection of toxin-induced acute kidney injury.

Authors:  Jamie R Privratsky; Nian Wang; Yi Qi; Jiafa Ren; Benjamin T Morris; John C Hunting; G Allan Johnson; Steven D Crowley
Journal:  Am J Physiol Renal Physiol       Date:  2018-12-05

2.  Protective effect of L-carnitine versus amifostine against cisplatin-induced nephrotoxicity in rats.

Authors:  Sernaz Uzunoglu; Hakan Karagol; Fulya Ozpuyan; Rusen Cosar; Irfan Cicin; Vuslat Yurutcaloglu; Bengü Denizli; Özgür Tanriverdi; Necdet Sut; Zafer Kocak
Journal:  Med Oncol       Date:  2010-12-08       Impact factor: 3.064

Review 3.  Cisplatin nephrotoxicity: a review of the literature.

Authors:  Sandhya Manohar; Nelson Leung
Journal:  J Nephrol       Date:  2017-04-05       Impact factor: 3.902

4.  Ifosfamide nephrotoxicity in adult patients.

Authors:  Gaël Ensergueix; Nicolas Pallet; Dominique Joly; Charlène Levi; Sophie Chauvet; Claire Trivin; Jean-Francois Augusto; Rémi Boudet; Hail Aboudagga; Guy Touchard; Dominique Nochy; Marie Essig; Eric Thervet; Hélène Lazareth; Alexandre Karras
Journal:  Clin Kidney J       Date:  2019-12-31

5.  Role of carnitine in cancer chemotherapy-induced multiple organ toxicity.

Authors:  Mohamed M Sayed-Ahmed
Journal:  Saudi Pharm J       Date:  2010-08-05       Impact factor: 4.330

Review 6.  Mechanisms of Cisplatin nephrotoxicity.

Authors:  Ronald P Miller; Raghu K Tadagavadi; Ganesan Ramesh; William Brian Reeves
Journal:  Toxins (Basel)       Date:  2010-10-26       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.